Cocrystal Pharma, Inc. (COCP) stock
COCPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$0.98−0.03 (-3.28%)
Close on Nov 18, 2026Market cap $18.82MP/E –Yield –
Cocrystal Pharma pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Cocrystal Pharma's pe ratio was 96.7× on Jan 31, 2019.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2019 | Jan 31, 2019 | 96.7× | −23.3 |
| 2018 | Dec 31, 2018 | 120.0× | – |
See a number that looks wrong?